Pure Healthcare

Deal Snapshot

Company: BUILD Infusion Holdings, LLC

Website: pureinfusionsuites.com

Sector / Category: Ambulatory infusion centers / specialty infusion care platform

Headquarters: Taylorsville, Utah, USA

Founded: 2018 (Pure Healthcare founded by BUILD Capital Partners)

Investor: Frazier VC

Investment Vehicle: Fund III

Deal Type: Primary

Company Overview

Pure Healthcare operates a national network of ambulatory infusion centers under Pure Infusion Suites, focused on providing infusion and injection therapy for complex chronic and autoimmune conditions in a private-suite setting.

Public Funding / Capital Events

Oct 7, 2019 — $40M funding round announced

Pure Healthcare (parent of Pure Infusion Suites) announced a $40M funding round led by BUILD Capital Partners to expand Pure Infusion Suites nationally.

Nov 24, 2025 — Merger completed with AleraCare

Business Wire reported the completion of the merger to create a larger national platform for ambulatory infusion and specialty care, with governance including representatives from Hildred and BUILD Capital Partners.

Investment Summary

Frazier VC Fund III made a primary investment in Pure (BUILD Infusion Holdings, LLC) in March 2022. This investment aligns with a scalable care-delivery platform built around outpatient infusion centers, where expansion can be driven through repeatable site rollout, payer partnerships, and standardized clinical operations.

Why We Invested

We invest in platforms with durable growth potential that can scale efficiently as demand expands. Pure’s ambulatory infusion model is designed to improve the patient experience while offering a lower-cost setting than hospital outpatient departments, and the operational playbook can expand across new markets. We also value businesses with meaningful execution advantages in regulated healthcare workflows, where payer relationships, clinical consistency, and site-level performance create real barriers to entry over time.

Other Investors

BUILD Capital Partners